Woodwork review

Woodwork is Grindr's telehealth brand, and its own homepage disclaimer is written in Grindr LLC's name. The GLP-1 page publishes four figures — $127 a month for compounded semaglutide, $199 for tirzepatide, $134 for a microdose program and $116 for sermorelin on the peptide page — and a footnote printed above the hero says the headline applies to a 48-week semaglutide injection plan. Forty-eight weeks is a commitment, not a month, and no shorter-term semaglutide price appears on any of the nine pages we read. The refund guidelines compound that: they calculate a prorated refund against what they call regular single-month pricing, a figure the site never prints. Two things are handled well. Compounded status is disclosed clearly and repeatedly — compounded products have not been approved by the FDA, and the FDA does not verify the safety or effectiveness of compounded drugs, both in plain sight rather than in a policy. And the service provider behind the platform is named with a street address, alongside the medical group. Against that, the only addresses Woodwork publishes for itself are post office boxes, no clinician is named, no state list exists — the terms claim capability in all fifty states and Washington DC and hedge it in the next sentence — and the terms name two pharmacies in the pharmacy clause while section 29 of the same page lists sixteen, several under different names than the clause uses. FDA warning-letter screen: NOT RUN. The only addresses published are post office boxes, and an entity screen that matches on domain and street address cannot discriminate against one.